RESOLUTION OF INFECTION STATUS OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-SEROINDETERMINATE DONORS AND HIGH-RISK SERONEGATIVE INDIVIDUALS WITH POLYMERASE CHAIN-REACTION AND VIRUS CULTURE - ABSENCE OF PERSISTENT SILENT HIV TYPE-1 INFECTION IN A HIGH-PREVALENCE AREA

被引:21
作者
EBLE, BE
BUSCH, MP
KHAYAMBASHI, H
NASON, MA
SAMSON, S
VYAS, GN
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143
[2] IRWIN MEM BLOOD CTR,DEPT EPIDEMIOL,SAN FRANCISCO,CA
[3] SAN FRANCISCO GEN HOSP,POLYMERASE CHAIN REACT CORE FACIL,CTR AIDS RES,SAN FRANCISCO,CA 94110
关键词
D O I
10.1046/j.1537-2995.1992.32692367191.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To address concerns over the prevalence of silent (antibody-negative) infections among blood donors and high-risk populations, a combination of proviral amplification by polymerase chain reaction (PCR) and viral isolation by co-culture techniques was employed to resolve the human immunodeficiency virus type 1 (HIV-1) infection status of well-characterized groups of suspect blood donors and others identified in the blood bank setting. No silent infections were found in 65 follow-up samples from 26 persistently HIV-1-seroindeterminate blood donors, 16 persistently seronegative heterosexual partners of infected transfusion recipients, and 6 high-risk seronegative homosexual men identified through donor look-back investigations. In contrast, 21 seropositive controls tested positive. These results suggest a low prevalence of persistently silent infections in at-risk populations, even in high HIV prevalence regions. The PCR assay, with a co-detected internal positive control, and appropriate confirmatory algorithms, was found to be a useful direct assay to rule out infection, especially in concert with confirmatory virus isolation.
引用
收藏
页码:503 / 508
页数:6
相关论文
共 44 条
[1]  
AIUTI F, 1989, NEW ENGL J MED, V321, P1679
[2]  
ALLAIN JP, 1986, LANCET, V2, P1233
[3]   ANTIBODIES TO THE NEF PROTEIN AND TO NEF PEPTIDES IN HIV-1-INFECTED SERONEGATIVE INDIVIDUALS [J].
AMEISEN, JC ;
GUY, B ;
CHAMARET, S ;
LOCHE, M ;
MOUTON, Y ;
NEYRINCK, JL ;
KHALIFE, J ;
LEPREVOST, C ;
BEAUCAIRE, G ;
BOUTILLON, C ;
GRASMASSE, H ;
MANIEZ, M ;
KIENY, MP ;
LAUSTRIAT, D ;
BERTHIER, A ;
MACH, B ;
MONTAGNIER, L ;
LECOCQ, JP ;
CAPRON, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (03) :279-291
[4]   IDENTIFICATION OF REGIONS OF HIV-1 P24 REACTIVE WITH SERA WHICH GIVE INDETERMINATE RESULTS IN ELECTROPHORETIC IMMUNOBLOTS WITH THE HELP OF LONG SYNTHETIC PEPTIDES [J].
BLOMBERG, J ;
VINCIC, E ;
JONSSON, C ;
MEDSTRAND, P ;
PIPKORN, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (12) :1363-1372
[5]   THE USE OF NON-RADIOACTIVE OLIGONUCLEOTIDE PROBES TO ANALYZE ENZYMATICALLY AMPLIFIED DNA FOR PRENATAL-DIAGNOSIS AND FORENSIC HLA TYPING [J].
BUGAWAN, TL ;
SAIKI, RK ;
LEVENSON, CH ;
WATSON, RM ;
ERLICH, HA .
BIO-TECHNOLOGY, 1988, 6 (08) :943-947
[6]  
BURKE DS, 1990, J ACQ IMMUN DEF SYND, V3, P1159
[7]  
BUSCH M, 1990, NEW ENGL J MED, V322, P850
[8]   RELIABLE CONFIRMATION AND QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ANTIBODY USING A RECOMBINANT-ANTIGEN IMMUNOBLOT ASSAY [J].
BUSCH, MP ;
ELAMAD, Z ;
MCHUGH, TM ;
CHIEN, D ;
POLITO, AJ .
TRANSFUSION, 1991, 31 (02) :129-137
[9]   INSITU HYBRIDIZATION AND IMMUNOCYTOCHEMISTRY FOR IMPROVED ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS CULTURES [J].
BUSCH, MP ;
RAJAGOPALAN, MS ;
GANTZ, DM ;
FU, SY ;
STEIMER, KS ;
VYAS, GN .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 88 (06) :673-680
[10]  
BUSCH MP, IN PRESS J AIDS